ゼリア新薬工業の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2017/08/31 | 2,025 | 2,025 | 2,009 | 2,017 | -3 | -0.1% | 110,700 |
| 2017/08/30 | 2,019 | 2,022 | 2,006 | 2,020 | +9 | +0.4% | 145,200 |
| 2017/08/29 | 2,012 | 2,016 | 2,003 | 2,011 | -4 | -0.2% | 107,400 |
| 2017/08/28 | 2,000 | 2,017 | 2,000 | 2,015 | +21 | +1.1% | 134,300 |
| 2017/08/25 | 1,949 | 1,995 | 1,947 | 1,994 | +55 | +2.8% | 145,200 |
| 2017/08/24 | 1,947 | 1,948 | 1,932 | 1,939 | -8 | -0.4% | 80,600 |
| 2017/08/23 | 1,963 | 1,963 | 1,937 | 1,947 | -3 | -0.2% | 119,100 |
| 2017/08/22 | 1,933 | 1,954 | 1,923 | 1,950 | -1 | -0.1% | 96,500 |
| 2017/08/21 | 1,959 | 1,959 | 1,939 | 1,951 | ±0 | ±0% | 81,700 |
| 2017/08/18 | 1,953 | 1,960 | 1,938 | 1,951 | -27 | -1.4% | 95,900 |
| 2017/08/17 | 1,983 | 1,993 | 1,965 | 1,978 | -5 | -0.3% | 88,200 |
| 2017/08/16 | 1,960 | 1,984 | 1,960 | 1,983 | +19 | +1% | 102,800 |
| 2017/08/15 | 1,963 | 1,974 | 1,953 | 1,964 | +7 | +0.4% | 109,700 |
| 2017/08/14 | 1,953 | 1,963 | 1,939 | 1,957 | +4 | +0.2% | 149,100 |
| 2017/08/10 | 1,959 | 1,967 | 1,927 | 1,953 | -7 | -0.4% | 235,600 |
| 2017/08/09 | 1,955 | 1,965 | 1,931 | 1,960 | -45 | -2.2% | 305,500 |
| 2017/08/08 | 2,043 | 2,059 | 1,995 | 2,005 | -33 | -1.6% | 226,500 |
| 2017/08/07 | 2,000 | 2,038 | 1,980 | 2,038 | +104 | +5.4% | 387,500 |
| 2017/08/04 | 1,949 | 1,949 | 1,915 | 1,934 | +7 | +0.4% | 83,900 |
| 2017/08/03 | 1,940 | 1,943 | 1,912 | 1,927 | -13 | -0.7% | 100,100 |
| 2017/08/02 | 1,925 | 1,947 | 1,913 | 1,940 | +17 | +0.9% | 102,100 |
| 2017/08/01 | 1,920 | 1,929 | 1,910 | 1,923 | -1 | -0.1% | 95,400 |
| 2017/07/31 | 1,934 | 1,945 | 1,921 | 1,924 | -16 | -0.8% | 83,900 |
| 2017/07/28 | 1,956 | 1,956 | 1,929 | 1,940 | -18 | -0.9% | 129,500 |
| 2017/07/27 | 1,959 | 1,972 | 1,951 | 1,958 | +5 | +0.3% | 92,600 |
| 2017/07/26 | 1,967 | 1,970 | 1,937 | 1,953 | -22 | -1.1% | 107,600 |
| 2017/07/25 | 2,018 | 2,018 | 1,973 | 1,975 | -39 | -1.9% | 103,900 |
| 2017/07/24 | 2,005 | 2,015 | 1,990 | 2,014 | +7 | +0.3% | 150,400 |
| 2017/07/21 | 2,011 | 2,016 | 2,001 | 2,007 | -4 | -0.2% | 159,200 |
| 2017/07/20 | 2,019 | 2,027 | 2,010 | 2,011 | -13 | -0.6% | 126,700 |
| 2017/07/19 | 2,030 | 2,039 | 2,018 | 2,024 | -16 | -0.8% | 201,700 |
| 2017/07/18 | 2,048 | 2,050 | 2,032 | 2,040 | -14 | -0.7% | 138,800 |
| 2017/07/14 | 2,057 | 2,067 | 2,043 | 2,054 | -2 | -0.1% | 163,900 |
| 2017/07/13 | 2,055 | 2,066 | 2,049 | 2,056 | +5 | +0.2% | 164,800 |
| 2017/07/12 | 2,090 | 2,092 | 2,035 | 2,051 | -57 | -2.7% | 563,500 |
| 2017/07/11 | 2,093 | 2,113 | 2,087 | 2,108 | +3 | +0.1% | 178,900 |
| 2017/07/10 | 2,115 | 2,115 | 2,085 | 2,105 | +1 | ±0% | 199,600 |
| 2017/07/07 | 2,103 | 2,124 | 2,099 | 2,104 | +1 | ±0% | 235,500 |
| 2017/07/06 | 2,112 | 2,123 | 2,097 | 2,103 | -5 | -0.2% | 222,100 |
| 2017/07/05 | 2,098 | 2,112 | 2,088 | 2,108 | +9 | +0.4% | 226,500 |
| 2017/07/04 | 2,114 | 2,123 | 2,095 | 2,099 | -3 | -0.1% | 272,700 |
| 2017/07/03 | 2,081 | 2,111 | 2,078 | 2,102 | +22 | +1.1% | 336,700 |
| 2017/06/30 | 2,057 | 2,090 | 2,043 | 2,080 | -1 | ±0% | 253,000 |
| 2017/06/29 | 2,080 | 2,082 | 2,058 | 2,081 | +8 | +0.4% | 249,300 |
| 2017/06/28 | 2,039 | 2,079 | 2,020 | 2,073 | +42 | +2.1% | 360,400 |
| 2017/06/27 | 2,018 | 2,038 | 2,011 | 2,031 | +19 | +0.9% | 281,200 |
| 2017/06/26 | 1,989 | 2,018 | 1,985 | 2,012 | +23 | +1.2% | 480,500 |
| 2017/06/23 | 1,989 | 1,998 | 1,972 | 1,989 | ±0 | ±0% | 311,200 |
| 2017/06/22 | 1,965 | 1,993 | 1,965 | 1,989 | +24 | +1.2% | 296,700 |
| 2017/06/21 | 1,967 | 1,988 | 1,950 | 1,965 | -2 | -0.1% | 378,600 |
1951～
2000
件表示中 / 3771件
類似銘柄と比較する
現在ご覧いただいている「ゼリア新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ゼリア新薬 | 203,900円 | +3.1% | -6.5% | 2.35% | 9.46倍 | 1.00倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| ジーエヌアイ | 265,800円 | +21.7% | +999.9% | 0.00% | 12.25倍 | 4.19倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| 持田薬 | 313,500円 | +5.1% | -7.0% | 2.55% | 20.58倍 | 0.85倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| 栄研化 | 249,200円 | +4.1% | -3.1% | 2.33% | 21.65倍 | 1.89倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割。尿検査（ウロ）、遺伝子検査も育成 |
| 杏林製薬 | 151,900円 | -2.4% | -52.3% | 3.75% | 18.18倍 | 0.64倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
市場注目の銘柄
チャート関連のコラム
